BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15328352)

  • 1. A novel snake venom vascular endothelial growth factor (VEGF) predominantly induces vascular permeability through preferential signaling via VEGF receptor-1.
    Takahashi H; Hattori S; Iwamatsu A; Takizawa H; Shibuya M
    J Biol Chem; 2004 Oct; 279(44):46304-14. PubMed ID: 15328352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crotalid venom vascular endothelial growth factors has preferential affinity for VEGFR-1. Characterization of Protobothrops mucrosquamatus venom VEGF.
    Chen YL; Tsai IH; Hong TM; Tsai SH
    Thromb Haemost; 2005 Feb; 93(2):331-8. PubMed ID: 15711751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A selective and oral small molecule inhibitor of vascular epithelial growth factor receptor (VEGFR)-2 and VEGFR-1 inhibits neovascularization and vascular permeability.
    Patel N; Sun L; Moshinsky D; Chen H; Leahy KM; Le P; Moss KG; Wang X; Rice A; Tam D; Laird AD; Yu X; Zhang Q; Tang C; McMahon G; Howlett A
    J Pharmacol Exp Ther; 2003 Sep; 306(3):838-45. PubMed ID: 12766257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snake venom VEGF Vammin induces a highly efficient angiogenic response in skeletal muscle via VEGFR-2/NRP specific signaling.
    Toivanen PI; Nieminen T; Laakkonen JP; Heikura T; Kaikkonen MU; Ylä-Herttuala S
    Sci Rep; 2017 Jul; 7(1):5525. PubMed ID: 28717175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF.
    Endo A; Fukuhara S; Masuda M; Ohmori T; Mochizuki N
    J Recept Signal Transduct Res; 2003; 23(2-3):239-54. PubMed ID: 14626450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src dependent pathway in retinal endothelial cells.
    Kalishwaralal K; Sheikpranbabu S; BarathManiKanth S; Haribalaganesh R; Ramkumarpandian S; Gurunathan S
    Angiogenesis; 2011 Mar; 14(1):29-45. PubMed ID: 21061058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain.
    Ogawa S; Oku A; Sawano A; Yamaguchi S; Yazaki Y; Shibuya M
    J Biol Chem; 1998 Nov; 273(47):31273-82. PubMed ID: 9813035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells.
    Grummer MA; Sullivan JA; Magness RR; Bird IM
    Biochem J; 2009 Jan; 417(2):501-11. PubMed ID: 18816248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt.
    Nishi J; Minamino T; Miyauchi H; Nojima A; Tateno K; Okada S; Orimo M; Moriya J; Fong GH; Sunagawa K; Shibuya M; Komuro I
    Circ Res; 2008 Aug; 103(3):261-8. PubMed ID: 18583712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor receptor-1 and receptor-2 initiate a phosphatidylinositide 3-kinase-dependent clonogenic response in acute myeloid leukemia cells.
    List AF; Glinsmann-Gibson B; Stadheim C; Meuillet EJ; Bellamy W; Powis G
    Exp Hematol; 2004 Jun; 32(6):526-35. PubMed ID: 15183893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a novel vascular endothelial growth factor (VEGF) with no affinity to heparin in Gloydius tsushimaensis venom.
    Nakamura H; Murakami T; Imamura T; Toriba M; Chijiwa T; Ohno M; Oda-Ueda N
    Toxicon; 2014 Aug; 86():107-15. PubMed ID: 24857790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.
    Huang Y; Chen X; Dikov MM; Novitskiy SV; Mosse CA; Yang L; Carbone DP
    Blood; 2007 Jul; 110(2):624-31. PubMed ID: 17376891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
    Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K
    Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability.
    Eriksson A; Cao R; Roy J; Tritsaris K; Wahlestedt C; Dissing S; Thyberg J; Cao Y
    Circulation; 2003 Mar; 107(11):1532-8. PubMed ID: 12654612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities.
    Joukov V; Kumar V; Sorsa T; Arighi E; Weich H; Saksela O; Alitalo K
    J Biol Chem; 1998 Mar; 273(12):6599-602. PubMed ID: 9506953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies.
    Shibuya M
    Genes Cancer; 2011 Dec; 2(12):1097-105. PubMed ID: 22866201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
    EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of VEGF-induced retinal vascular permeability by peroxisome proliferator-activated receptor-β/δ.
    Suarez S; McCollum GW; Bretz CA; Yang R; Capozzi ME; Penn JS
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8232-40. PubMed ID: 25406289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Snake venom vascular endothelial growth factors (VEGFs) exhibit potent activity through their specific recognition of KDR (VEGF receptor 2).
    Yamazaki Y; Takani K; Atoda H; Morita T
    J Biol Chem; 2003 Dec; 278(52):51985-8. PubMed ID: 14600159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
    Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
    Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.